🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/08/2024 | 116,30 | 116,72 | 115,22 | 116,55 | +0,45% | 1,29% | 8.201.200 |
| 21/08/2024 | 114,78 | 116,60 | 114,55 | 116,03 | +0,77% | 1,79% | 8.144.100 |
| 20/08/2024 | 114,76 | 115,30 | 114,55 | 115,14 | +0,63% | 0,65% | 5.392.300 |
| 19/08/2024 | 113,66 | 114,60 | 113,31 | 114,42 | +0,66% | 1,13% | 6.177.500 |
| 16/08/2024 | 113,61 | 113,72 | 112,62 | 113,67 | +0,32% | 0,97% | 10.102.300 |
| 15/08/2024 | 114,17 | 114,50 | 112,57 | 113,31 | -0,24% | 1,69% | 9.685.100 |
| 14/08/2024 | 113,66 | 113,93 | 111,51 | 113,58 | -0,71% | 2,13% | 11.029.400 |
| 13/08/2024 | 113,57 | 114,87 | 112,84 | 114,39 | +0,80% | 1,79% | 9.040.300 |
| 12/08/2024 | 114,71 | 114,71 | 113,11 | 113,48 | -0,93% | 1,39% | 6.536.000 |
| 09/08/2024 | 113,78 | 114,72 | 112,87 | 114,55 | +0,55% | 1,63% | 5.914.100 |
| 08/08/2024 | 112,92 | 114,23 | 112,57 | 113,92 | +1,27% | 1,47% | 8.278.200 |
| 07/08/2024 | 111,68 | 112,55 | 110,72 | 112,49 | +1,21% | 1,64% | 9.756.500 |
| 06/08/2024 | 112,30 | 113,08 | 110,92 | 111,15 | -1,03% | 1,92% | 9.761.900 |
| 05/08/2024 | 114,95 | 115,12 | 111,34 | 112,31 | -2,51% | 3,29% | 13.334.000 |
| 02/08/2024 | 115,16 | 117,30 | 114,36 | 115,20 | +1,21% | 2,55% | 16.562.300 |
| 01/08/2024 | 113,13 | 114,47 | 111,41 | 113,82 | +0,61% | 2,70% | 14.117.500 |
| 31/07/2024 | 116,00 | 117,84 | 112,22 | 113,13 | -1,84% | 4,84% | 22.733.000 |
| 30/07/2024 | 123,48 | 123,94 | 113,91 | 115,25 | -9,81% | 8,12% | 35.509.400 |
| 29/07/2024 | 125,78 | 127,99 | 124,92 | 127,78 | +2,01% | 2,44% | 9.139.500 |
| 26/07/2024 | 127,24 | 128,73 | 125,05 | 125,26 | -0,47% | 2,89% | 6.467.000 |
| 25/07/2024 | 126,03 | 127,85 | 125,71 | 125,85 | -0,06% | 1,70% | 7.357.100 |
| 24/07/2024 | 124,97 | 126,17 | 124,68 | 125,92 | +1,24% | 1,19% | 6.338.500 |
| 23/07/2024 | 124,99 | 125,62 | 124,18 | 124,38 | -1,04% | 1,15% | 4.285.400 |
| 22/07/2024 | 125,95 | 126,49 | 125,03 | 125,69 | -0,06% | 1,16% | 4.341.800 |
| 19/07/2024 | 125,30 | 126,99 | 125,18 | 125,77 | +1,22% | 1,44% | 6.848.800 |
| 18/07/2024 | 125,30 | 125,60 | 122,37 | 124,25 | -1,30% | 2,58% | 9.501.400 |
| 17/07/2024 | 125,47 | 126,69 | 124,56 | 125,89 | +0,36% | 1,70% | 7.628.000 |
| 16/07/2024 | 127,87 | 129,03 | 125,20 | 125,44 | -2,09% | 3,00% | 8.194.400 |
| 15/07/2024 | 128,00 | 128,34 | 127,20 | 128,12 | +0,28% | 0,89% | 6.918.500 |
| 12/07/2024 | 129,40 | 129,93 | 127,32 | 127,76 | -0,94% | 2,02% | 7.022.300 |